Hongyang Huang

1.1k total citations · 1 hit paper
14 papers, 758 citations indexed

About

Hongyang Huang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Hongyang Huang has authored 14 papers receiving a total of 758 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Hongyang Huang's work include Cancer, Hypoxia, and Metabolism (4 papers), RNA modifications and cancer (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). Hongyang Huang is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), RNA modifications and cancer (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). Hongyang Huang collaborates with scholars based in China, Hong Kong and United States. Hongyang Huang's co-authors include Jinzhou Huang, Guang‐Rong Yan, Huifang Zhu, Song Zhu, Min Chen, De Chen, Min Hu, Irene Oi‐Lin Ng, Yu‐Man Tsui and Karen Man‐Fong Sze and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Molecular Cell.

In The Last Decade

Hongyang Huang

12 papers receiving 756 citations

Hit Papers

A Peptide Encoded by a Putative lncRNA HOXB-AS3 Suppresse... 2017 2026 2020 2023 2017 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hongyang Huang China 9 649 497 65 58 52 14 758
Eduardo López–Urrutia Mexico 15 515 0.8× 462 0.9× 41 0.6× 86 1.5× 36 0.7× 30 714
Jia Chen China 15 362 0.6× 344 0.7× 44 0.7× 50 0.9× 39 0.8× 38 536
Radu Pîrlog Romania 11 316 0.5× 236 0.5× 64 1.0× 86 1.5× 42 0.8× 35 492
Lorenza Di Ianni Italy 10 301 0.5× 227 0.5× 31 0.5× 82 1.4× 30 0.6× 10 442
Haolin Yun China 12 430 0.7× 233 0.5× 70 1.1× 70 1.2× 70 1.3× 13 617
Yanan Bu China 11 422 0.7× 282 0.6× 39 0.6× 63 1.1× 57 1.1× 15 628
Guo Pin China 12 335 0.5× 188 0.4× 33 0.5× 81 1.4× 22 0.4× 30 455

Countries citing papers authored by Hongyang Huang

Since Specialization
Citations

This map shows the geographic impact of Hongyang Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongyang Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongyang Huang more than expected).

Fields of papers citing papers by Hongyang Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongyang Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongyang Huang. The network helps show where Hongyang Huang may publish in the future.

Co-authorship network of co-authors of Hongyang Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Hongyang Huang. A scholar is included among the top collaborators of Hongyang Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongyang Huang. Hongyang Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Huang, Hongyang, Dandan Zeng, Rong Liang, et al.. (2025). Postoperative Adjuvant Transcatheterarterial Chemoembolization Should Be Considered Selectively for Patients with Cytokeratin-19 Positive Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. Volume 12. 2407–2419.
2.
Cai, Meng‐Ting, Hongyang Huang, Yiheng Zhang, et al.. (2025). A pectic polysaccharide from wax gourd peel improves ethanol-induced gastric ulcer injury in mice via the PI3K/AKT signaling pathway. International Journal of Biological Macromolecules. 316(Pt 2). 144755–144755.
3.
Zhang, Xin, Qingyang Zhang, Karen Man‐Fong Sze, et al.. (2024). Targeting the oncogenic m6A demethylase FTO suppresses tumourigenesis and potentiates immune response in hepatocellular carcinoma. Gut. 74(1). 90–102. 41 indexed citations
4.
Huang, Hongyang, Yu‐Man Tsui, & Irene Oi‐Lin Ng. (2023). Fueling HCC Dynamics: Interplay Between Tumor Microenvironment and Tumor Initiating Cells. Cellular and Molecular Gastroenterology and Hepatology. 15(5). 1105–1116. 15 indexed citations
5.
Wang, Xia, Hongyang Huang, Karen Man‐Fong Sze, et al.. (2023). S100A10 promotes HCC development and progression via transfer in extracellular vesicles and regulating their protein cargos. Gut. 72(7). 1370–1384. 27 indexed citations
6.
Huang, Hongyang, Yu‐Man Tsui, Daniel Wai‐Hung Ho, et al.. (2023). LANCL1, a cell surface protein, promotes liver tumor initiation through FAM49B-Rac1 axis to suppress oxidative stress. Hepatology. 79(2). 323–340. 7 indexed citations
7.
Gao, Ming, Min Deng, Hongyang Huang, et al.. (2022). The deubiquitinase USP7 regulates oxidative stress through stabilization of HO-1. Oncogene. 41(33). 4018–4027. 24 indexed citations
8.
Gao, Ming, Wenya Feng, Hongyang Huang, et al.. (2022). m6A demethylation of cytidine deaminase APOBEC3B mRNA orchestrates arsenic-induced mutagenesis. Journal of Biological Chemistry. 298(2). 101563–101563. 20 indexed citations
9.
Zhu, Qian, Jinzhou Huang, Hongyang Huang, et al.. (2021). RNF19A-mediated ubiquitination of BARD1 prevents BRCA1/BARD1-dependent homologous recombination. Nature Communications. 12(1). 16 indexed citations
10.
Zhang, Xin, Karen Man‐Fong Sze, Lo‐Kong Chan, et al.. (2021). Antioxidant supplements promote tumor formation and growth and confer drug resistance in hepatocellular carcinoma by reducing intracellular ROS and induction of TMBIM1. Cell & Bioscience. 11(1). 217–217. 31 indexed citations
11.
Chen, Ao, Fan Yang, Jing Kuang, et al.. (2021). A Versatile Nanoplatform for Broad-Spectrum Immunotherapy by Reversing the Tumor Microenvironment. ACS Applied Materials & Interfaces. 13(38). 45335–45345. 8 indexed citations
12.
Huang, Jinzhou, Min Chen, De Chen, et al.. (2017). A Peptide Encoded by a Putative lncRNA HOXB-AS3 Suppresses Colon Cancer Growth. Molecular Cell. 68(1). 171–184.e6. 541 indexed citations breakdown →
13.
Huang, Hongyang, Min Chen, Jinzhou Huang, et al.. (2017). POU2F1 over-expression correlates with poor prognoses and promotes cell growth and epithelial-to-mesenchymal transition in hepatocellular carcinoma. Oncotarget. 8(27). 44082–44095. 22 indexed citations
14.
Liu, W.K., et al.. (2002). Growth inhibitory activity of lemnabourside on human prostate cancer cells. Life Sciences. 70(7). 843–853. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026